Drugs · Entity Annotation Prototype (beta)

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Glucagon-like peptide-1 analogues ×

Glucagon-like peptide-1 analogues

This drug is selected. Its supporting articles are shown below.

Glucagon-like peptide-1 analogues2

Articles mentioning Glucagon-like peptide-1 analogues

2 articles · page 1 of 1

Effects of glucagon-like peptide-1 analogues on hard binary outcomes for patients at increased risk of cardiovascular events: a protocol for a systematic review with network meta-analysis and Trial Sequential Analysis

bmjopen · abstract · 2025-12-10 · 1 matching annotations

87.8%

Semaglutide tirzepatide liraglutide CagriSema Glucagon-like peptide-1 analogues type 2 diabetes chronic kidney disease Cardiovascular diseases

…se in patients with cardiovascular disease and type 2 diabetes. Semaglutide, tirzepatide and liraglutide are approved by the US Food and Dr…

Prevalence and risk factors of atherosclerotic cardiovascular disease in Egyptians with type 2 diabetes: findings from the PACT-MEA study and call for action

bmjopen · abstract · 2025-08-03 · 1 matching annotations

96.9%

glucagon-like peptide-1 analogues sodium-glucose cotransporter-2 inhibitors eASCVD T2DM ASCVD Type 2 Diabetes ESC